Please login to the form below
COVID-19 Updates and Daily News
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- UK trial of fourth vaccine dose shows increased protection against COVID-19
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
- Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
- BMA appoints two internal candidates to share the role of chief executive officer
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- FREE Live Webinar - Accelerating Patient recruitment in Clinical Trials post COVID-19 - 8th June 2022
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Roche shares new positive Ocrevus data for MS patients
- First trial of a vaccine against Alzheimer’s launches
- David Hunt launches independent agency The Considered
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
- How scientific storytelling can help Pharma cut through the noise
- Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...
